Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion By: TalkMarkets April 06, 2024 at 14:20 PM EDT ProfoundBio will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. The acquisition will expand Genmab’s drug portfolio, including three ProfoundBio clinical stage ADC candidates for solid tumors. Read More >> Related Stocks: Ascendis Pharma ADR Bristol-Myers Squibb China Medical System Holdings Ltd Genmab A/S ADR Hutchmed China Ltd ADR Incyte Corp Innovent Biologics Inc Zai Lab Ltd ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion By: TalkMarkets April 06, 2024 at 14:20 PM EDT ProfoundBio will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. The acquisition will expand Genmab’s drug portfolio, including three ProfoundBio clinical stage ADC candidates for solid tumors. Read More >> Related Stocks: Ascendis Pharma ADR Bristol-Myers Squibb China Medical System Holdings Ltd Genmab A/S ADR Hutchmed China Ltd ADR Incyte Corp Innovent Biologics Inc Zai Lab Ltd ADR